Susquehanna Portfolio Strategies’s Collegium Pharmaceutical COLL Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	39,295 +33,085	+533%	+$1.13M	0.02%	497
2026 Q1	$205K	Sell	6,210 -42,598	-87%	-$1.8M	﹤0.01%	900
2025 Q4	$2.26M	Buy	48,808 +34,033	+230%	+$1.42M	0.03%	470
2025 Q3	$517K	Buy	14,775 +7,435	+101%	+$258K	0.01%	831
2025 Q2	$217K	Buy	+7,340	New	+$209K	﹤0.01%	789

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Susquehanna Portfolio Strategies's COLL Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Collegium Pharmaceutical (COLL) stake by 533% in Q2 2026, buying an estimated $1.13M and bringing the position to 39,295 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #497.

Susquehanna Portfolio Strategies first reported a position in COLL in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.26M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Susquehanna Portfolio Strategies held 39,295 shares of Collegium Pharmaceutical worth $1.42M as of Q2 2026.
Susquehanna Portfolio Strategies bought 33,085 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.13M.
Collegium Pharmaceutical made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #497 holding.
Susquehanna Portfolio Strategies first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
Susquehanna Portfolio Strategies's Collegium Pharmaceutical position peaked at $2.26M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.